Document Page: First | Prev | Next | All | Image | This Release | Search

File: 970107_sep96_decls33_0004.txt
Page: 0004
Total Pages: 7

Subject: PREVENTION OF HEPATITIS A IN SOLDIERS                           

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003205

Folder Title: HEPATITIS A - VACCINES                                                                          

Document Number:          1

Folder Seq  #:         62








                                                             Percent with neutralizing antibody
                      Group Received Nunber Month 0 Month I Month 6 Month 8
                         1 HAV Needle 10                           0          50                  90         100
                         2 HAV Jetcjun 10                          0          60                  90         100

                      Side effects
                                                   Following Dose 1
                                                                                            Am.
                      Group     NLn Feverish Headache Malaise Nausea vomiting xyatgia Swollen Red Sore
                      Needle     91     3%         Is     4        7       1        15      3     2   40
                      JetG@      96     6          9      5        I       0        10      19    22  43
                      ...............................................................................
                                                   Following Dose 2
                      Needle     72     0%         6      0        3       0        10      13    0   19
                      JetGm      73     4          3      3        1       0        10      10    15  30
                      ...............................................................................

                                                   Following Dose 3
                      Needle 60         3%         3      2        0       0        8       5     5   22
                      JetGm 70          1          1      0        0       0        7       16    19  20

                                            (3)    Conclusions

                                                   (a) Three doses of this preparation provides a
                                                   high level of antibody to nearly all recipients.

                                                   (b) The vaccine is safe and well tolerated. It
                                            would minimally disrupt unit acitivities.

                                     b. Rapid immunization schedules using higher potency
                                     vaccine.

                                     Selected data from studies carried out in Europe are
                                     presented here. These data indicate that the vaccine
                                     would stimulate antibody in all recipients, and that
                                     antibody would persist at least 9 months. One
                                     limitation of this data is that it is based on the
                                     results of an ELISA test rather than a neutralizing
                                     antibody test.

                                           (1) Results

                      Percent of initially non-immune volunteers with antibody
                      following administration of IIM-175 vaccine. The geometric mean
                      titer is shown in the line below.

                      Schedule                     < --- Time of Sample (days following first dose) --- >
                      (Days)                       14         30           60               120            180              270
                      0, 14 Percent                44%      100%         100%               100%           100%             100%
                                 GMT               259      596          418                350            243              181







                                                                            3

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 7 f:/Week-36/BX003205/HEPATITIS A - VACCINES/prevention of hepatitis a in soldiers:01029715472734
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003205
Unit = OTSG
Parent Organization = HSC
Folder Title = HEPATITIS A - VACCINES
Folder Seq # = 62
Subject = PREVENTION OF HEPATITIS A IN SOLDIERS
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997